New insight into ALS disease origins leads to targeted novel therapies The Thierry Latran Foundation selected in 2013 the innovative project: Normalization of the blood-brain barrier deficiency in ALS with inhibitors of the Platelet-Derived Growth Factor CC (PDGF-CC) pathway. The...
The Thierry Latran Foundation 7th Call for projects opened in November 2014 to finance research with potential therapeutic benefit in sporadic ALS on the following themes: Biological markers, pathological pathways and mechanisms, therapeutic strategies, innovative molecules in the fields...
The Thierry Latran Foundation was established in 2008 to a) finance basic, applied and clinical research with potential therapeutic benefit in sporadic Amyotrophic Lateral Sclerosis and b) to support academic and industrial scientific research efforts in Europe to cure...
To explore neuroinflammation to find a therapeutic pathway Cédric Raoul presents the main outcome of his project This project was selected during the first call for projects of the Thierry Latran Foundation to understand the molecular nature of the...
A revolutionary tool to find new therapeutic avenues The innovative project based on iPS cells proposed by Delphine Bohl was selected in 2010 Project. Her very interesting results have been recently published, she comments them for the Foundation Human induced...
The emerging understanding of the role of G-quadruplexes in neurodegenerative diseases raises new possibilities for therapeutic intervention The research project led by Pr Adrian Isaacs, Department of Neurodegenerative Disease, Institute of Neurology at UC, was selected in 2013. During...
The discovery of a prognostic biomarker in ALS Within the prestigious University of Oxford (ranked for 2014-2015 as number one University in Health Science by the Times Magazine), Dr. Martin Turner undertakes a cutting- edge research on biomarkers. ...
An important result: The ANGIOGENIN project opens the way to a pharmaceutical development of a new treatment. The only objective of the Thierry Latran Foundation is to accelerate research to find a treatment. The selected projects must of...
Optogenetically-Controlled Restoration of Muscle Function in ALS to control breathing in ALS patients without the need for mechanical ventilation This avant-guarde project is managed through a collaborative work between University College London, Dr Barney Bryson in the team of...
Identification of pathways of degeneration and protection in ALS using oculomotor neuron resistance as a tool. Eva Hedlund, associate professor in the department of Neuroscience at Karolinska Institute in Sweden and Stefania Corti associate professor in the Neurology unit...